Asher Biotherapeutics Stock

asherbio.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $166.65MM

Asher Bio is a biotech company developing precisely targeted immunotherapies for cancer and other diseases.

Register for Details

For more details on financing and valuation for Asher Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Asher Biotherapeutics.

Register Today

Other companies like Asher Biotherapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B